| Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans PS Arunachalam, F Wimmers, CKP Mok, RAPM Perera, M Scott, T Hagan, ... Science 369 (6508), 1210-1220, 2020 | 1174 | 2020 |
| Emerging concepts in the science of vaccine adjuvants B Pulendran, P S. Arunachalam, DT O’Hagan Nature Reviews Drug Discovery 20 (6), 454-475, 2021 | 1060 | 2021 |
| Systems vaccinology of the BNT162b2 mRNA vaccine in humans PS Arunachalam, MKD Scott, T Hagan, C Li, Y Feng, F Wimmers, ... Nature 596 (7872), 410-416, 2021 | 471 | 2021 |
| Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination K Röltgen, SCA Nielsen, O Silva, SF Younes, M Zaslavsky, C Costales, ... Cell 185 (6), 1025-1040. e14, 2022 | 437 | 2022 |
| Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine C Li, A Lee, L Grigoryan, PS Arunachalam, MKD Scott, M Trisal, ... Nature immunology 23 (4), 543-555, 2022 | 359 | 2022 |
| Adjuvanting a subunit COVID-19 vaccine to induce protective immunity PS Arunachalam, AC Walls, N Golden, C Atyeo, S Fischinger, C Li, P Aye, ... Nature 594 (7862), 253-258, 2021 | 318 | 2021 |
| Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines AC Walls, MC Miranda, A Schäfer, MN Pham, A Greaney, ... Cell 184 (21), 5432-5447. e16, 2021 | 166 | 2021 |
| T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers PS Arunachalam, TP Charles, V Joag, VS Bollimpelli, MKD Scott, ... Nature medicine 26 (6), 932-940, 2020 | 153 | 2020 |
| Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses BL Sievers, S Chakraborty, Y Xue, T Gelbart, JC Gonzalez, AG Cassidy, ... Science translational medicine 14 (634), eabn7842, 2022 | 107 | 2022 |
| Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity S Chakraborty, JC Gonzalez, BL Sievers, V Mallajosyula, S Chakraborty, ... Science Translational Medicine 14 (635), eabm7853, 2022 | 106 | 2022 |
| Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia NJ Dashdorj, OF Wirz, K Röltgen, E Haraguchi, AS Buzzanco, M Sibai, ... Cell host & microbe 29 (12), 1738-1743. e4, 2021 | 79 | 2021 |
| Durability of immune responses to mRNA booster vaccination against COVID-19 PS Arunachalam, L Lai, H Samaha, Y Feng, M Hu, HS Hui, B Wali, M Ellis, ... The Journal of clinical investigation 133 (10), 2023 | 63 | 2023 |
| A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates PAB Weidenbacher, M Sanyal, N Friedland, S Tang, PS Arunachalam, ... Nature Communications 14 (1), 2149, 2023 | 60 | 2023 |
| Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+ T cell responses post SARS-CoV-2 infection F Gao, V Mallajosyula, PS Arunachalam, K van der Ploeg, M Manohar, ... Immunity 56 (4), 864-878. e4, 2023 | 59* | 2023 |
| Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in … S Pillet, PS Arunachalam, G Andreani, N Golden, J Fontenot, PP Aye, ... Cellular & molecular immunology 19 (2), 222-233, 2022 | 51 | 2022 |
| Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine PS Arunachalam, Y Feng, U Ashraf, M Hu, AC Walls, VV Edara, ... Science translational medicine 14 (658), eabq4130, 2022 | 50 | 2022 |
| mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognition K Röltgen, SCA Nielsen, PS Arunachalam, F Yang, RA Hoh, OF Wirz, ... MedRxiv, 2021 | 47 | 2021 |
| Durability of immune responses to the BNT162b2 mRNA vaccine MS Suthar, PS Arunachalam, M Hu, N Reis, M Trisal, O Raeber, ... Med 3 (1), 25-27, 2022 | 45 | 2022 |
| Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice L Grigoryan, A Lee, AC Walls, L Lai, B Franco, PS Arunachalam, Y Feng, ... npj Vaccines 7 (1), 55, 2022 | 39 | 2022 |
| BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance A Lee, K Floyd, S Wu, Z Fang, TK Tan, HM Froggatt, JM Powers, SR Leist, ... Nature Immunology 25 (1), 41-53, 2024 | 37 | 2024 |
